Iceland vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Access to anti-retroviral drugs, male
Iceland
89.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
22.9%
in 2024
Iceland rank
17th
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank
18th
Access to anti-retroviral drugs, male over time
- Iceland
- Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
How they compare
Iceland currently reports 89.0% against 22.9% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 66.1%.
That makes Iceland's figure about 3.9 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.
Across all 25 years both countries report, Iceland has been ahead every year.
Iceland ranks 17th and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 18th of 141 countries.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iceland | Middle East, North Africa, Afghanistan & Pakistan (excluding high income) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.3% | 3.3% | 42.0% | Iceland |
| 2010s | 68.6% | 10.3% | 58.3% | Iceland |
| 2020s | 86.4% | 19.4% | 67.0% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Iceland or Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- Iceland, at 89.0% against 22.9% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Iceland and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- 66.1%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- 25 years are reported by both, from 2000 to 2024.
- How do Iceland and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank globally for access to anti-retroviral drugs, male?
- Iceland ranks 17th and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 18th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.